From: Multiple primary tumors: a case report and review of the literature
Author, year | Age/Gender | Tumors | Type | Survival | Genetic test |
---|---|---|---|---|---|
Mussari [9], 2000 | 47/M | Anus/ Esophagus/ Lung/ Oral cavity | N/A | N/A | N/A |
48/M | Lung/ Stomach/ Rectum/ Lung | N/A | N/A | N/A | |
55/M | Oral cavity/ Oropharynx/ Esophagus/ Melanoma | N/A | N/A | N/A | |
60/M | Oral cavity/ Larynx/ Lymphoma/ Esophagus | N/A | N/A | N/A | |
Noh [10], 2008 | 68/F | Breast cancer/ Rectal adenocarcinoma/ Ovary carcinoma/ Endometrium carcinoma | Metachronous | N/A | N/A |
Angurana [11], 2010 | 35/F | Infiltrating duct cell carcinoma Breast carcinoma/ Early infiltrating duct cell carcinoma of breast carcinoma/ Adenocarcinoma endometrium/ Esophagus carcinoma | Metachronous | 30 years | N/A |
Jiao [12], 2013 | 64/M | Small intestine adenocarcinoma/ Colon adenocarcinoma/ Urothelial carcinoma of the pelvis/ Pancreatic cancer | Metachronous | 20 years | N/A |
KIM [13], 2013 | 73/F | Thyroid carcinoma/ Breast carcinoma/ Pancreatic carcinoma/ Gastrointestinal stromal tumor | Synchronous | 8 months (DOD) | N/A |
Milosevic [14], 2014 | 40/F | Medullary thyroid carcinoma/ Micropapillary thyroid carcinoma/ Melanoma/ Breast carcinoma | Metachronous | N/A | PTEN/P53 /RET/HRAS/KRAS |
Kousaka [15], 2014 | 41/F | Osteosarcoma/ Tongue cancer/ Thyroid cancer/ Breast carcinoma | Metachronous | 3 months | N/A |
Grace [16], 2015 | 70/M | Glioblastoma/ Schwannoma/ Neuroendocrine tumor/ Adenoma | Synchronous | N/A | EGFR /CDKN2A/2B/PTEN |
Meeks [17], 2016 | 95/F | Adenocarcinoma/ Adenoma/ Neuroendocrine tumor/ Schwann cell hamartoma | Synchronous | N/A | N/A |
Elec [18], 2017 | 78/M | Prostate adenocarcinoma/ Clear-cell renal carcinoma/ Papillary renal carcinoma/ Bladder cancer | Synchronous | 4 years | N/A |
Nanashima [19], 2017 | 67/M | Stomach/ Sigmoid colon/ Rectum/ Pancreas carcinomas | Synchronous | 4.25 years | N/A |
Wang [20], 2019 | 56/F | Cervix/ Endometrium/ Ovary/ Stomach carcinomas | Synchronous | 1 year | N/A |